Clinical examination of hepatocellular carcinoma treated at the department of surgery, public fujioka general hospital.

DOI

この論文をさがす

抄録

We clinically examined 137 patients with hepatocellular carcinoma (99 males, 38 females, mean age : 65.7 years) who were treated at the Department of Surgery, Public Fujioka General Hospital between June 1989 and December 1997. The proportion of HBsAg-positive patients was 5.1%. The proportion of HCV-positive patients was 83.2%. The incidence of liver cirrhosis was 90%.<BR>The clinical stage was evaluated as I in 24.8% of the patients, II in 54.0% of the patients and III in 21.2% of the patients. In most patients, hepatic functional reserve was reduced. Concerning the number of tumors, 46% of the patients had solitary tumor, while 25.5% of the patients had 5 or more tumors. More than half the patients had multiple tumors. The maximal mean tumor diameter was 5.6 cm. According to staging, 5.8%, 29.9%, 10.2%, 46.0% and 8.0% of the patients had stage-I, -II, -III, -IV A and-IV B lesions, respectively.<BR>Surgery was performed in 22.6% of the patients. There were no surgical deaths. In the hepatectomy group, 1-year, 3-year and 5-year cumulative survival rates were 84.6%, 63.8% and 54.9%, respectively. In the TAE group, 1-year and 3-year cumulative survival rates were 54.9% and 24.9%, respectively. In the LPD group, 1-year, 3-year and 5-year cumulative survival rates were 68.4%, 13.0% and 13.0%, respectively. In the arterial infusion group with a reservoir, the 1-year cumulative survival rate was 31.5%.<BR>Therefore, hepatectomy may be effective for patients in whom surgery is possible. In patients in whom surgery is impossible, TAE, LPD and arterial infusion with a reservoir may prolong survival.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ